Advances in Traditional Medicine

Kyung Hee Oriental Medicine Research Center (경희대학교 융합한의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

Anti-inflammatory effect of Equisetum hyemale via suppression of nuclear factor-κB activation in human mast cells

  • Jeon, So-Ra (Department of Oriental Pharmacy. College of Pharmacy, Woosuk University) ;
  • Na, Ho-Jeong (Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Johns Hopkins Asthma Center) ;
  • Jeon, Hoon (Department of Oriental Pharmacy. College of Pharmacy, Woosuk University)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Equisetum hyemale Linne. (EH) (Equisetaceae) has been used for the treatment of eye and skin disease, chronic eczema, pneumoconiosis and asthma in Korea and China. Human leukemic mast cells are widely distributed in the connective tissues of mammals and other vertebrates. Phorbol 12-myristrate 13-acetate (PMA) and calcium ionophore A23187 stimulated Human leukaemic mast cell line-1 (HMC-1) can produce a variety of inflammatory mediators and several pro-inflammatory and chemotactic cytokines such as TNF-$\alpha$, IL-6 and IL-8. Since TNF-$\alpha$, IL-6 and IL-8 are major factors during the inflammatory process, we studied the effects of EH on TNF-$\alpha$, IL-6 and IL-8 release in HMC-1 stimulated with PMA and A23187. The result of this study indicate that EH inhibits TNF-$\alpha$, IL-6 and IL-8 in activated HMC-1 cells via $I{\kappa}B$/Nuclear factor-${\kappa}B$ pathway. Therefore, EH might contribute significantly to the prevention or treatment of mast-cell mediated inflammatory diseases and EH has potential use in the therapy of chronic allergic inflammation.

Keywords

References

  1. Annelie M, Undine L, Bietlinde L, Gerd k, Katrin H, Pia W, Dirk S, Thomas R, Thomas L, Beate MC. (1993) Human mast cells produce IL-8. J. Immunol. 151, 3261-3266
  2. Arend WP, Dayer JM. (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38, 151–160 https://doi.org/10.1002/art.1780380202
  3. Azzolina A, Bongiovanni A, Lampiasi N. (2003) Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells, Biochim. Biophys. Acta 1643, 75–83 https://doi.org/10.1016/j.bbamcr.2003.09.003
  4. Baeuerle PA, Baltimore D. (1996) NF-kappa B: ten years after. Cell 87, 13-20 https://doi.org/10.1016/S0092-8674(00)81318-5
  5. Baeuerie PA, Henkel T. (1994) Function and activation of NF-eB in the immune system. Annu. Rev. Immu. 12, 141–179
  6. Baumgartner RA, Yamada K, Deramo VA, Beaven MA. (1994) Secretion of TNF-$\alpha$ from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process. J. Immunol. 153, 2609–2617
  7. Beaven MA, Metzger H. (1993) Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol. Today 14, 222–226 https://doi.org/10.1016/0167-5699(93)90167-J
  8. Church MK, Levi-Schaffer F. (1997) The human mast cell. J. Allergy Clin. Immunol. 99, 155–160 https://doi.org/10.1016/S0091-6749(97)70089-7
  9. Collart MA, Baeuerle P, Vassaili P. (1990) Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four $\kappa$B-like motifs and of constitutive and inducible forms of NF-$\kappa$B. Mol. Cell. Biol. 10, 1498–1506
  10. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-$\kappa$B. Nature 388, 548–554 https://doi.org/10.1038/41493
  11. Ershler WB, Keller ET. (2000) Age-associated increased interleukin-6 gene expression, late-life disease, and frailty. Annu. Rev. Med. 51, 245-270 https://doi.org/10.1146/annurev.med.51.1.245
  12. Fiorini E, Marchisio PC, Scupoli MT, Poffe O, Tagliabue E, Brentegani M, Colombatti M, Santini F, Tridente G, Ramarli D. (2000) Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. Dev. Immunol. 7, 195–208 https://doi.org/10.1155/2000/48239
  13. Galien R, Evans HF, Garcia T. (1996) Involvment of CCAAT/enhancer-binding protein and nuclear factorkappa B binding site in interleukin-6 promoter inhibition by estrogens. Mol. Endocrinol. 10, 713–722 https://doi.org/10.1210/me.10.6.713
  14. Galli SJ. (1993) New concepts about the mast cell. New Engl. J. Med. 328, 257-265 https://doi.org/10.1056/NEJM199301283280408
  15. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. (2005) Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749–786 https://doi.org/10.1146/annurev.immunol.21.120601.141025
  16. Galli SJ, Zsebo KM, Geissler EN. (1994) The kit ligand, stem cell factor. Adv. Immunol. 55, 1-96 https://doi.org/10.1016/S0065-2776(08)60508-8
  17. Grimm S, Baeuerle PA. (1993) The inducible transcription factor NF-$\kappa$B: structure-function relationship of its protein subunits. Biochem. J. 290, 297-308 https://doi.org/10.1042/bj2900297
  18. Hide I, Toriu N, Nuibe T, Inoue A, Hide M, Yamamoto S, Nakata Y. (1997) Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. J. Immunol. 159, 2932–2940
  19. Hong CH, Hur SK, Oh OJ, Kim SS, Nam KA, Lee SK. (2002) Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J. Ethnopharmacol. 83, 153-159 https://doi.org/10.1016/S0378-8741(02)00205-2
  20. Hosoda M, Yamaya M, Suzuki T, Yamada N, Kamanaka M, Sekizawa K, Butterfield JH, Watanabe T, Nishimura H, Sasaki H. (2002) Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J. Immunol. 169, 1482–1491
  21. Hu MCT, Wang Y. (1998) I$\kappa$B kinase-$\alpha$ and -$\beta$ genes are coexpressed adult and embryonic tissues but localized to different human chromosomes. Gut 222, 31–40
  22. Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, Kim HM. (2003) Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem. Biophys. Res. Commun. 306, 805–811 https://doi.org/10.1016/S0006-291X(03)01073-8
  23. Jeong HJ, Koo HN, Na HJ, Kim MS, Hong SH, Eom JW, Kim KS, Shin TY, Kim HM. (2002) Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine 18, 252–259 https://doi.org/10.1006/cyto.2002.0894
  24. Jeong HJ, Lee SA, Moon PD, Na HJ, Park RK, JY, Kim HM, Hong SH. (2006) Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-kappaB activation. Clin. Exp. Allergy 36, 785–794 https://doi.org/10.1111/j.1365-2222.2006.02508.x
  25. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan SD, Anderson M, Sunouchi K, Major J, Hamilton T, Kuwabara K, Rot A, Nowygrod R, Stern D. (1994) Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93, 1564–1570 https://doi.org/10.1172/JCI117135
  26. Kemp SF, Lockey RF. (2002) Anaphylaxis: a review of causes and mechanisms. J. Allergy Clin. Immunol. 110, 341–348 https://doi.org/10.1067/mai.2002.126811
  27. Kim HM, Lee YM. (1999) Role of TGF-beta 1 on the IgE-dependent anaphylaxis reaction. J. Immunol. 162, 4960-4965
  28. Kim MS, Na HJ, Han SW, Jin JS, Song UY, Lee EJ, Song BK, Hong SH, Kim HM. (2003) Forsythia fructus inhibits the mast-cell-mediated allergic inflammatory reactions. Inflammation 27, 129–135 https://doi.org/10.1023/A:1023865727780
  29. Krishnaswamy G, Ajitawi O, Chi DS. (2006) The human mast cell: an overview. Methods Mol. Biol. 315, 13-34 https://doi.org/10.1385/1-59259-967-2:013
  30. Lee SI et al. (1995) Oriental Herb Medicine Bonchohak. Young-lim's publications 157-158
  31. May MJ, Ghosh S. (1997) Rel/NF$\kappa$B and I$\kappa$B protein: an overview. Semin. Cancer Biol. 8, 63–73 https://doi.org/10.1006/scbi.1997.0057
  32. Metcalfe DD, Baram D, Mekori Ya. (1997) Mast cells. Physiol. Rev. 77, 1033-1079 https://doi.org/10.1152/physrev.1997.77.4.1033
  33. Moon PD, Lee BH, Jeong HJ, An HJ, Park SJ, Kim HR, Ko SG, Um JY, Hong SH, Kim HM. (2007) Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition of the IkappaB/NFkappaB signal cascade in the human mast cell line HMC-1. Eur. J. Pharmacol. 555, 218-225 https://doi.org/10.1016/j.ejphar.2006.10.021
  34. Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y. (1990) Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol. Lett. 25, 355–357 https://doi.org/10.1016/0165-2478(90)90207-7
  35. Rao A. (1994) NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 15, 274–281 https://doi.org/10.1016/0167-5699(94)90007-8
  36. Regnier CH, Song H, Gao H, Goeddel DV, Cao Z, Rothe M. (1997) Identification and characterization of an I$\kappa$B kinase. Cell 90, 373–383 https://doi.org/10.1016/S0092-8674(00)80344-X
  37. Schoonbroodt S, Legrand-Poels S, Best-Belpomme M, Piette J. (1997) Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 321, 777–785
  38. Sengupta B, Banerjee A, Sengupta PK. (2004) Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Lett. 570, 77–81 https://doi.org/10.1016/j.febslet.2004.06.027
  39. Snick J. (1990) Interleukin-6: an overview. Annu. Rev. Immunol. 8, 253–278 https://doi.org/10.1146/annurev.iy.08.040190.001345
  40. Tetlow LC, Woolley DE. (1995) Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann. Rheum. Dis. 54, 549–555 https://doi.org/10.1136/ard.54.7.549
  41. Thanos D, Maniatis T. (1995) NF-$\kappa$B: a lesson in family values. Cell 80, 529-532 https://doi.org/10.1016/0092-8674(95)90506-5
  42. Wahl C, Liptay S, Adler G, Schmid RM. (1998) Sulfasalazine: potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101, 1163–1174 https://doi.org/10.1172/JCI992
  43. Xu CF, Bian XY, Qu SM, You LH, Qi ZM, Cheng W, Liu XJ, Liu WZ, Ren SJ. (1993) Effect of Equisetum hyemale on experimental hyperlipemia in rats and its toxic test. Zhongguo Zhong Yao Za Zhi 18, 52-53, 64